A reaction product comprising equal quantities of (S)- α-cyano-3-phenoxybenzyl (Z)-(1R,3R)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-
dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S,3S)-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate
Lambda-cyhalothrin content 100 g/l (± 10% of the declared content).
The “free” (“non-encapsulated”) lambda-cyhalothrin content shall not exceed 4% of the total lambda-cyhalothrin content.
The release of lambda-cyhalothrin from the capsules shall be:
at 15 min, 30 to 75% of that released at 180 min; and
at 30 min, 50 to 90% of that released at 180 min; and
at 180 min, a minimum of 80% of the total lambda-cyhalothrin content.
A minimum of 75% of the lambda-cyhalothrin content shall be in suspension after 30 minutes in CIPAC standard water D at 30 ± 20C.
A maximum of 0.1% w/w shall be retained on a 75 µm test sieve.